One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma
Jian-Yu E, MD, ScD, MPH; Aleksandra Mihailovic, ScM; Catalina Garzon, BS; et al.
Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract SurgeryA Randomized Clinical Trial
Jesper Høiberg Erichsen, MD, PhD; Lars M. Holm, MD, PhD; Mads Forslund Jacobsen, MD, PhD; et al.
Female Editorial Authorship Trends in High-Impact Ophthalmology Journals
Cherie A. Fathy, MD, MPH; Elliot Cherkas, BS; Charlotte N. Shields, BS; et al.
Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room SettingsA Meta-analysis
Tong Li, MD; Junran Sun, MD; Jingyu Min, MD; et al.
Association of Variants in TMEM45A With Keratoglobus
Chen Weiner, MSc; Idan Hecht, MD; Alina Kotlyar, BSc; et al.
Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia
Ran Du, MD; Shiqi Xie, MD; Tae Igarashi-Yokoi, MD; et al.
Effect of a Randomized Interventional School-Based Vision Program on Academic Performance of Students in Grades 3 to 7A Cluster Randomized Clinical Trial
Amanda J. Neitzel, PhD; Betsy Wolf, PhD; Xinxing Guo, MD, PhD; et al.
Rates of Myopia Development in Young Chinese Schoolchildren During the Outbreak of COVID-19
Yin Hu, MD; Feng Zhao, MD, PhD; Xiaohu Ding, MD, PhD; et al.
Evaluation of a Series of Wrong Intravitreous Injections
Robin A. Vora, MD; Amar Patel, MD; Michael I. Seider, MD; et al.
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor–Associated Retinopathy
Jasmine H. Francis, MD; James J. Harding, MD; Alison M. Schram, MD; et al.
Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi
Francesco Pichi, MD; Shaikha Aljneibi, MD; Piergiorgio Neri, MD, PhD; et al.
Severe Glaucoma Associated With Changes in Gait Over Time
Felipe A. Medeiros, MD, PhD
Status of Women in Ophthalmology in 2021—Different Year, Same Story?
Kathryn Colby, MD, PhD
Another Insight Into COVID-19–Associated Nearsightedness
David C. Musch, PhD, MPH
COVID-19, COVID-19 Vaccinations, and Subsequent Abnormalities in the RetinaCausation or Coincidence?
Lee M. Jampol, MD; Robert Tauscher, MD; Hans Peter Schwarz, MD
Bilateral Disc Edema Masquerade
Alex Pai, AB; Steven Carter, MD; Lilangi S. Ediriwickrema, MD
A Man Who Cannot Elevate His Right Eye or Abduct His Left Eye
Jennifer Ling, MSc; Andrew Micieli, MD; Jonathan A. Micieli, MD
Severe Headaches in a Young Adult With Progressive Bilateral Vision Loss
Travis Peck, MD; Samir N. Patel, MD; Sonia Mehta, MD
Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity
Raymond T. Kraker, MSPH; David K. Wallace, MD, MPH; Roy W. Beck, MD, PhD; et al.
Prominent Subfoveal Choroidal Vessel Potentially Masquerading as a Nematode
Robin K. Kuriakose, MD; David R. P. Almeida, MD, MBA, PhD; Eric K. Chin, MD
Widefield Swept-Source Optical Coherence Tomography Angiography of a “Polypoidal-Like� Retinal Arteriovenous Anastomosis in Proliferative Diabetic Retinopathy
Mengxi Shen, MD; Rita Laiginhas, MD; Philip J. Rosenfeld, MD, PhD
Considerations When Using a Statistical Learning Model to Predict Corneal Edema Resolution
Gil Neuman, MD
Considerations When Using a Statistical Learning Model to Predict Corneal Edema Resolution—Reply
Daniel Zander, BSc; Thomas Reinhard, MD; Katrin Wacker, MD
Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study
Douglas R. Anderson, MD
Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study—Reply
Michael A. Kass, MD; Mae O. Gordon, PhD
